Investors in Life Sciences

Padda health is a VALUE CREATOR VENTURE CAPITAL that invests in innovative start-ups and SMEs in the healthcare area, sustaining them with a value generating skills network, through Padda Innovation Town. Padda health possesses a vision of open innovation on a global scale, while featuring the relationships usually connected with a family office. Padda health moves quickly, creating and providing value, turning start-ups into great game changers through something worth much more than money, i.e. human capital. Padda health is a start-up enabler that, by making use of a network of professionals in the fields of marketing, HR, procurement, legal and finance, aims to support the key areas during all the development stages of the start-ups

At Korify, the team focuses on investing in innovative and visionary companies that have the potential to shape the future they envision. Korify Capital is focused on three investment strategies: Distributed development companies, Enabling technologies and domain-specific platforms.

Monograph Capital is a venture firm focused on life sciences. With a dedicated emphasis on the life sciences sector, Monograph Capital invests in innovative companies and technologies that aim to advance healthcare and biotechnology. The firm supports early-stage ventures as well as growth-stage companies, providing critical capital, strategic guidance, and industry expertise to drive their development and success. Monograph Capital's investments span across biotech, pharmaceuticals, medical devices, and other areas within the life sciences field, aiming to contribute to breakthrough discoveries, therapies, and medical advancements. Through its strategic investments, Monograph Capital plays a crucial role in accelerating innovation and improving health outcomes globally.

BOM Brabant Ventures is the venture capital arm of Brabant Development Agency (BOM), focusing on investments in innovative companies across the Dutch province of North Brabant. As a regional development agency, BOM Brabant Ventures plays a vital role in supporting the growth and competitiveness of local businesses. The firm targets early-stage and growth-stage companies operating in sectors such as high-tech systems & materials, life sciences & health, agri-food, and sustainable energy. BOM Brabant Ventures provides financial investment, strategic guidance, and access to its extensive network of partners and industry experts to help startups scale their operations and enter new markets. By fostering innovation and entrepreneurship, BOM Brabant Ventures contributes to the economic development of North Brabant, creating job opportunities and stimulating technological advancements. The firm also collaborates closely with other regional and national stakeholders to strengthen the innovation ecosystem and attract talent and investment to the region.

Humanity will always depend on medicines. Continuous innovation in the biotech sector is a given. Bringing better medicines to the market all the time. The Aescap Life Sciences and Aescap Genetics funds invest in highly innovative publicly traded biotech/life sciences companies. These companies are developing tomorrow’s medicines. Investing in Aescap funds offers the possibility to achieve excellent returns over the medium term, without taking large risks. Both funds have a focused portfolio, based on deep fundamental analyses and a strict buy and sell discipline. The Aescap funds act under the Article 8 of the EU Sustainable Finance Disclosure Regulation (SFDR) and operate under a AIFM license.

MedSciences Capital (MSC) is a dedicated venture capital provider focused on supporting early- and mid-stage companies at the forefront of developing innovative products in the healthcare and life sciences sectors. With a mission to drive advancements in medical technologies and healthcare solutions, MedSciences Capital strategically invests in companies poised to make significant impacts on patient care and industry standards. Their investment approach combines financial support with strategic guidance and operational expertise, helping entrepreneurs navigate challenges and scale their innovations effectively. MSC's portfolio spans a wide range of healthcare innovations, including medical devices, biotechnology advancements, pharmaceuticals, and digital health solutions. By fostering partnerships and leveraging their extensive network, MedSciences Capital plays a crucial role in accelerating the development and commercialization of groundbreaking healthcare technologies that address global health challenges.

Boundary Capital Partners LLP is a venture capital firm specializing in early-stage growth companies, primarily within the technology sector. By offering both financial investment and hands-on support, Boundary Capital Partners helps innovative tech startups achieve their growth potential. Their investment approach combines capital with strategic guidance, leveraging their expertise and network to drive business success. Committed to fostering technological advancement, Boundary Capital Partners partners with visionary entrepreneurs to build the next generation of market-leading companies.

Advent Life Sciences is a venture capital firm dedicated to investing in life sciences businesses. Focusing on innovative companies in biotechnology, pharmaceuticals, medical devices, and diagnostics, Advent Life Sciences supports the development of breakthrough technologies and therapies. By providing capital and strategic expertise, the firm helps entrepreneurs navigate the complexities of the life sciences sector, accelerating the path from research to market. Advent Life Sciences is committed to advancing healthcare solutions that improve patient outcomes and address unmet medical needs globally.

McWin is a private investment firm that focuses on Food Tech, Life Science, Clean Tech, Mobility Space Tech, Digitalization, and Fintech.McWin is a private equity firm founded by Henry McGovern and Steven K. Winegar partnering with exceptional founders and CEOs daring sustainable disruption, principally in the foodservice and food technology sectors.

Integra Holdings is a unique venture fund that combines academic excellence, funding and R&D guidance together with a strong and proven business network — the most important elements necessary to bring academic innovation to the market. Focusing on an exclusive selection of biotech companies with proprietary solutions and a competitive advantage in their respective fields, Integra takes a hands-on approach by providing our portfolio companies the strategic planning and business development necessary to bring their technology to the market. Founded by Yissum, the Hebrew University's technology transfer company, Integra capitalizes on the innovative applied research constantly flowing from the renowned Hebrew University of Jerusalem, Israel.

Since 1998, we at Auriga Partners have supported entrepreneurs from the creation of their company through all stages of development, up to their exit via merger and acquisition or IPO. As pioneers in venture capital in France, we have reinvented ourselves into a multi-specialist investor, dedicated to bringing together specific expertise on future themes or territories—both in unlisted and listed companies.

i&i Prague is a bio-innovation center partner for biotech innovations and smart money investments.i&i Prague is located in the heart of Europe, specializing in identifying and investing in new inventions in Drug Discovery, Diagnostics, MedTech, and other Life Science fields. They support projects from academic institutions.